{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T19:00:05Z","timestamp":1781290805870,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,15]]},"DOI":"10.7759\/cureus.80633","type":"journal-article","created":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T00:40:36Z","timestamp":1742085636000},"source":"Crossref","is-referenced-by-count":1,"title":["Macrophage Activation Syndrome in Adult-Onset Still\u2019s Disease: Challenges in Early Detection and Management"],"prefix":"10.7759","author":[{"given":"Anil","family":"Regmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecelia","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin  K","family":"Kinduell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sampath  K","family":"Ethiraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Still disease","author":"Bhargava J","year":"2024","unstructured":"Bhargava J, Panginikkod S. Still disease. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref2","article-title":"On a form of chronic joint disease in children","volume":"80","author":"Still GF","year":"1897","unstructured":"Still GF. On a form of chronic joint disease in children. Med Chir Trans. 1897, 80:47-60.","journal-title":"Med Chir Trans"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780250607","article-title":"Adult-onset Still's disease. Twenty-year follow-up and further studies of patients with active disease","volume":"25","author":"Elkon KB","year":"1982","unstructured":"Elkon KB, Hughes GR, Bywaters EG, et al.. Adult-onset Still's disease. Twenty-year follow-up and further studies of patients with active disease. Arthritis Rheum. 1982, 25:647-54. 10.1002\/art.1780250607","journal-title":"Arthritis Rheum"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000021","article-title":"Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients","volume":"93","author":"Gerfaud-Valentin M","year":"2014","unstructured":"Gerfaud-Valentin M, Maucort-Boulch D, Hot A, et al.. Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients. Medicine (Baltimore). 2014, 93:91-9. 10.1097\/MD.0000000000000021","journal-title":"Medicine (Baltimore)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.43052","article-title":"Macrophage activation syndrome","author":"Nigrovic PA","year":"2024","unstructured":"Nigrovic PA. Macrophage activation syndrome. Arthritis Rheumatol. 2024, 10.1002\/art.43052","journal-title":"Arthritis Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2008.08.006","article-title":"Adult-onset Still disease","volume":"22","author":"Fautrel B","year":"2008","unstructured":"Fautrel B. Adult-onset Still disease. Best Pract Res Clin Rheumatol. 2008, 22:773-92. 10.1016\/j.berh.2008.08.006","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcps2111163","article-title":"Calm before the storm","volume":"386","author":"Braga Neto MB","year":"2022","unstructured":"Braga Neto MB, Badley AD, Parikh SA, Graham RP, Kamath PS. Calm before the storm. N Engl J Med. 2022, 386:479-85. 10.1056\/NEJMcps2111163","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/03009740600958504","article-title":"Increased ferritin response in adult Still's disease: specificity and relationship to outcome","volume":"36","author":"Evensen KJ","year":"2007","unstructured":"Evensen KJ, Swaak TJ, Nossent JC. Increased ferritin response in adult Still's disease: specificity and relationship to outcome. Scand J Rheumatol. 2007, 36:107-10. 10.1080\/03009740600958504","journal-title":"Scand J Rheumatol"},{"key":"ref9","article-title":"Diagnostic value of ferritin and glycosylated ferritin in adult onset Still\u2019s disease","volume":"28","author":"Fautrel B","year":"2001","unstructured":"Fautrel B, Le Mo\u00ebl G, Saint-Marcoux B, et al.. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still\u2019s disease. J Rheumatol. 2001, 28:322-9.","journal-title":"J Rheumatol"},{"key":"ref10","article-title":"Preliminary criteria for classification of adult Still\u2019s disease","volume":"19","author":"Yamaguchi M","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, et al.. Preliminary criteria for classification of adult Still\u2019s disease. J Rheumatol. 1992, 19:424-30.","journal-title":"J Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.07.005","article-title":"Validation of the Fautrel classification criteria for adult-onset Still's disease","volume":"47","author":"Lebrun D","year":"2018","unstructured":"Lebrun D, Mestrallet S, Dehoux M, et al.. Validation of the Fautrel classification criteria for adult-onset Still's disease. Semin Arthritis Rheum. 2018, 47:578-85. 10.1016\/j.semarthrit.2017.07.005","journal-title":"Semin Arthritis Rheum"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3830-3","article-title":"Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients","volume":"36","author":"Ruscitti P","year":"2017","unstructured":"Ruscitti P, Rago C, Breda L, et al.. Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. Clin Rheumatol. 2017, 36:2839-45. 10.1007\/s10067-017-3830-3","journal-title":"Clin Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2019.04.004","article-title":"Racial\/Ethnic variations in morbidity and mortality in adult onset Still's disease: an analysis of national dataset","volume":"49","author":"Mehta BY","year":"2019","unstructured":"Mehta BY, Ibrahim S, Briggs W, Efthimiou P. Racial\/Ethnic variations in morbidity and mortality in adult onset Still's disease: an analysis of national dataset. Semin Arthritis Rheum. 2019, 49:469-73. 10.1016\/j.semarthrit.2019.04.004","journal-title":"Semin Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-04949-0","article-title":"Macrophage activation syndrome associated with adult-onset Still's disease: a multicenter retrospective analysis","volume":"39","author":"Wang R","year":"2020","unstructured":"Wang R, Li T, Ye S, et al.. Macrophage activation syndrome associated with adult-onset Still's disease: a multicenter retrospective analysis. Clin Rheumatol. 2020, 39:2379-86. 10.1007\/s10067-020-04949-0","journal-title":"Clin Rheumatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2021.06.004","article-title":"Adult-onset Still's disease in focus: clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies","volume":"51","author":"Efthimiou P","year":"2021","unstructured":"Efthimiou P, Kontzias A, Hur P, Rodha K, Ramakrishna GS, Nakasato P. Adult-onset Still's disease in focus: clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies. Semin Arthritis Rheum. 2021, 51:858-74. 10.1016\/j.semarthrit.2021.06.004","journal-title":"Semin Arthritis Rheum"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000451","article-title":"Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patients","volume":"94","author":"Bae CB","year":"2015","unstructured":"Bae CB, Jung JY, Kim HA, Suh CH. Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patients. Medicine (Baltimore). 2015, 94:e451. 10.1097\/MD.0000000000000451","journal-title":"Medicine (Baltimore)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(87)90015-1","article-title":"Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failure","volume":"17","author":"Reginato AJ","year":"1987","unstructured":"Reginato AJ, Schumacher HR Jr, Baker DG, O'Connor CR, Ferreiros J. Adult onset Still's disease: experience in 23 patients and literature review with emphasis on organ failure. Semin Arthritis Rheum. 1987, 17:39-57. 10.1016\/0049-0172(87)90015-1","journal-title":"Semin Arthritis Rheum"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/art.40865","article-title":"Treatment to target using recombinant interleukin-1 receptor antagonist as first-line monotherapy in new-onset systemic juvenile idiopathic arthritis: results from a five-year follow-up study","volume":"71","author":"Ter Haar NM","year":"2019","unstructured":"Ter Haar NM, van Dijkhuizen EH, Swart JF, et al.. Treatment to target using recombinant interleukin-1 receptor antagonist as first-line monotherapy in new-onset systemic juvenile idiopathic arthritis: results from a five-year follow-up study. Arthritis Rheumatol. 2019, 71:1163-73. 10.1002\/art.40865","journal-title":"Arthritis Rheumatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30096-5","article-title":"Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome","volume":"2","author":"Mehta P","year":"2020","unstructured":"Mehta P, Cron RQ, Hartwell J, Manson JJ, Tattersall RS. Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome. Lancet Rheumatol. 2020, 2:e358-67. 10.1016\/S2665-9913(20)30096-5","journal-title":"Lancet Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/319226-macrophage-activation-syndrome-in-adult-onset-stills-disease-challenges-in-early-detection-and-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T00:40:38Z","timestamp":1742085638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/319226-macrophage-activation-syndrome-in-adult-onset-stills-disease-challenges-in-early-detection-and-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,15]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.80633","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,15]]}}}